Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLARIS: Levalbuterol vs Racemic Albuterol in Inpatients with Asthma or COPD
NCT00667797Phase 4Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Mar 2003
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levalbuterol in asthma, chronic obstructive pulmonary disease (COPD), sponsored by Sumitomo Pharma America. Started Mar 2003; status: completed.
02
Drugs
levalbuterol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00667797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667797.